Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: A population-based study in the Netherlands

Critical Reviews in Oncology/Hematology

Volumn 62, Issue 2, 2007, Pages 172-178

  Janssen Heijnen, M L G ^a   Lemmens, V E P P ^a,e   van den Borne, B E E M ^b   Biesma, B ^c   Oei, S B ^d   Coebergh, J W W ^a,e  

^a Eindhoven Cancer Registry   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Comorbidity; Elderly; Population based; Prognosis; Side effects of treatment; Small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ABSCESS; ADULT; AGED; ANEMIA; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; LEUKOPENIA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PNEUMONIA; PROGNOSIS; REVIEW; SEPTICEMIA; THROMBOCYTOPENIA; THROMBOEMBOLISM; UNSPECIFIED SIDE EFFECT; WOUND INFECTION;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; COMORBIDITY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; RADIOTHERAPY; SURVIVAL ANALYSIS;

EID: 34147140542     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2006.11.005     Document Type: Review

References (35)

1. Janssen-Heijnen M.L., and Coebergh J.W. The changing epidemiology of lung cancer in Europe. Lung Cancer 41 (2003) 245-258
2. Ihde D.C. Chemotherapy of lung cancer. N Engl J Med 327 (1992) 1434-1441
3. Janssen-Heijnen M.L., Schipper R.M., Klinkhamer P.J., Crommelin M.A., and Coebergh J.W. Improvement and plateau in survival of small-cell lung cancer since 1975: a population-based study. Ann Oncol 9 (1998) 543-547
4. Shepherd F.A., Amdemichael E., Evans W.K., et al. Treatment of small cell lung cancer in the elderly. J Am Geriatr Soc 42 (1994) 64-70
5. Arriagada R., Pignon J.P., Ihde D.C., et al. Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2140 patients. Anticancer Res 14 (1994) 333-335
6. Pignon J.P., Arriagada R., Ihde D.C., et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327 (1992) 1618-1624
7. Turrisi A.T., and Sherman C.A. The treatment of limited small cell lung cancer: a report of the progress made and future prospects. Eur J Cancer 38 (2002) 279-291
8. Monfardini S. Prescribing anti-cancer drugs in elderly cancer patients. Eur J Cancer 38 (2002) 2341-2346
9. Hutchins L.F., Unger J.M., Crowley J.J., Coltman Jr. C.A., and Albain K.S. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341 (1999) 2061-2067
10. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
11. Mountain C.F. A new international staging system for lung cancer. Chest 89 (1986) 225S-233S
12. Lebitasy M.P., Hedelin G., Purohit A., Moreau L., Klinzig F., and Quoix E. Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994. Br J Cancer 85 (2001) 808-815
13. Laskin J.J., Erridge S.C., Coldman A.J., et al. Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia. Lung Cancer 43 (2004) 7-16
14. Jara C., Gomez-Aldaravi J.L., Tirado R., Meseguer V.A., Alonso C., and Fernandez A. Small-cell lung cancer in the elderly-is age of patient a relevant factor?. Acta Oncol 38 (1999) 781-786
15. Dajczman E., Fu L.Y., Small D., Wolkove N., and Kreisman H. Treatment of small cell lung carcinoma in the elderly. Cancer 77 (1996) 2032-2038
16. Brown J.S., Eraut D., Trask C., and Davison A.G. Age and the treatment of lung cancer. Thorax 51 (1996) 564-568
17. Mahmud S.M., Reilly M., and Comber H. Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study. Lung Cancer 41 (2003) 57-64
18. de Rijke J.M., Schouten L.J., Schouten H.C., Jager J.J., Koppejan A.G., and van den Brandt P.A. Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol 7 (1996) 677-685
19. Weinmann M., Jeremic B., Bamberg M., and Bokemeyer C. Treatment of lung cancer in elderly part II: small cell lung cancer. Lung Cancer 40 (2003) 1-16
20. Siu L.L., Shepherd F.A., Murray N., Feld R., Pater J., and Zee B. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 14 (1996) 821-828
21. Deppermann K.M. Influence of age and comorbidities on the chemotherapeutic management of lung cancer. Lung Cancer 33 Suppl. 1 (2001) S115-S120
22. Quoix E., Breton J.L., Daniel C., et al. Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study. Ann Oncol 12 (2001) 957-962
23. Satoh H., Ishikawa H., Funayama Y., et al. Management of small cell lung cancer in elderly. Anticancer Res 19 (1999) 4507-4510
24. Nou E. Full chemotherapy in elderly patients with small cell bronchial carcinoma. Acta Oncol 35 (1996) 399-406
25. Yuen A.R., Zou G., Turrisi A.T., et al. Similar outcome of elderly patients in intergroup trial 0096: cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer 89 (2000) 1953-1960
26. Larive S., Bombaron P., Riou R., et al. Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial. Lung Cancer 35 (2002) 1-7
27. Gridelli C., De Vivo R., and Monfardini S. Management of small-cell lung cancer in the elderly. Crit Rev Oncol Hematol 41 (2002) 79-88
28. Tebbutt N.C., Snyder R.D., and Burns W.I. An analysis of the outcomes of treatment of small cell lung cancer in the elderly. Aust NZ J Med 27 (1997) 160-164
29. Osterlind K., and Andersen P.K. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 46 (1986) 4189-4194
30. Rawson N.S., and Peto J. An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. Br J Cancer 61 (1990) 597-604
31. Yip D., and Harper P.G. Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer 28 (2000) 173-185
32. Piccirillo J.F., Tierney R.M., Costas I., Grove L., and Spitznagel Jr. E.L. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291 (2004) 2441-2447
33. Albain K.S., Crowley J.J., LeBlanc M., and Livingston R.B. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 8 (1990) 1563-1574
34. Messori A., Trippoli S., and Tendi E. G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation. J Clin Pharm Ther 21 (1996) 57-63
35. Quon H., Shepherd F.A., Payne D.G., et al. The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 43 (1999) 39-45